Davion Healthcare Secures £30 Million Bond for Acquisitions

Davion Healthcare Plc, an Irish public limited company focused on healthcare technologies and products, has secured a £30 million senior secured bond that has been admitted to trading on the Vienna MTF, operated by the Vienna Stock Exchange. This financing will provide the company with a dedicated capital source to support its acquisition-led growth strategy.

The bond, issued by Davion Healthcare Finance Ltd, a dedicated financing subsidiary of the company, commenced in August 2026. It carries a fixed annual coupon of 10.5% and will be used to fund the acquisition of healthcare businesses and assets across various sectors, including medical devices, diagnostics, medical distribution, healthcare technology, and healthcare services. The company is particularly interested in established, cash-generative businesses that can contribute earnings to the Group and provide a platform for further growth.

Jack Kaye, Chief Executive Officer of Davion Healthcare Plc, commented, "The admission of our £30 million bond to the Vienna MTF gives Davion the capital to pursue the acquisition opportunities we are already evaluating across the healthcare sector. We are looking for established, cash-generative businesses that can contribute earnings to the Group from day one, while adding products, customers, and distribution capabilities."

The bond provides Davion with additional capacity to pursue acquisitions, aiming to expand its portfolio of products and businesses and build its international distribution network. The proceeds will be deployed on an acquisition-by-acquisition basis through Davion Healthcare Finance Ltd, with security granted over the relevant assets acquired using those proceeds.

Key terms of the bond include: - Issuer: Davion Healthcare Finance Ltd - Principal amount: Up to £30 million - Ranking: Senior secured - Term: Five years - Commencement: August 2026 - Annual coupon: 10.5% fixed - Trading venue: Vienna MTF, operated by Wiener Börse AG - ISIN: GB00BTH2SB89 - Denomination: £100,000

The admission of the bond to trading on the Vienna MTF provides Davion with an additional source of acquisition finance alongside its wider corporate funding plans. This financing is expected to accelerate the company's expansion and diversification efforts in the international healthcare market.

Davion Healthcare Plc continues to focus on developing its international commercial and distribution capabilities alongside its acquisition strategy. The company aims to build a larger and more diversified international healthcare group by combining its own products with established operating businesses and distribution networks.